EC-2629

N/A

Report date: 2025/02/24 15:11:09
NME

Base Information

Drug NameEC-2629
Drug Alias NameEC-2629
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA cross linking agentsFolate receptor alpha antagonists
TargetsDNAFolate receptor alpha
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEndocyte Inc
China Registration ClassN/A

Develop Information

Active CompaniesEndocyte Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A